Evidence map›Paper›PMID 37046476›Full record

ArticleDiagnostics (Basel, Switzerland)2023

Evaluation of Celligent

Raúl Capote-Puente, José-María Sánchez-González, María Carmen Sánchez-González, María-José Bautista-Llamas

Open access · goldAbstract read
In one paragraph

Article in Diagnostics (Basel, Switzerland), 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
3.2field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 11 citations in OpenAlex.

  1. Article
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Raúl Capote-PuenteOptica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.
José-María Sánchez-GonzálezOptica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.ORCID 0000-0003-0450-7717
María Carmen Sánchez-GonzálezOptica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.ORCID 0000-0002-9453-8615
María-José Bautista-LlamasOptica Area, Vision Research Group (CIVIUS), Department of Physics of Condensed Matter, Faculty of Pharmacy, University of Seville, 41012 Seville, Spain.ORCID 0000-0001-8317-5014
Universidad de Sevilla · ES

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

This study aimed to evaluate the non-invasive and subjective symptoms associated with Lehfilcon A water gradient silicone hydrogel contact lenses with bacterial and lipid resistance technology. A prospective, longitudinal, single-centre, self-controlled study was conducted among silicone hydrogel contact lens wearers. Non-invasive analysis of the pre-lens tear film was performed using the Integrated Clinical Platform (ICP) Ocular Surface Analyzer (OSA), and the meibomian glands were evaluated with the Cobra

Indexed as

contact lenslipid patternnon-invasive break-up timepre-lens tear film

Identifiers

PMID37046476
PMCPMC10093668
OpenAlexW4361224513

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.